| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.05. | Cardiol Therapeutics Inc. - 6-K, Report of foreign issuer | 67 | SEC Filings | ||
| 14.05. | Cardiol Therapeutics Inc.: Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024 | 394 | Newsfile | Scope of presentation included trial design, rationale, and blinded baseline data on first 50 patients randomized into the Phase II study evaluating CardiolRx in patients with acute myocarditis ARCHER... ► Artikel lesen | |
| 14.05. | Cardiol Therapeutics Inc. - 6-K, Report of foreign issuer | 15 | SEC Filings | ||
| 26.04. | Cardiol Therapeutics Inc. - 6-K, Report of foreign issuer | 66 | SEC Filings | ||
| 02.04. | Cardiol Therapeutics Inc: Cardiol Therapeutics recaps 2023 operations | 34 | Stockwatch | ||
| 02.04. | Cardiol Therapeutics Inc. - 6-K, Report of foreign issuer | 18 | SEC Filings | ||
| 02.04. | Cardiol Therapeutics Inc.: Cardiol Therapeutics Announces Year-End 2023 Update on Operations | 345 | Newsfile | Completed patient enrollment in the Phase II MAvERIC-Pilot study evaluating CardiolRx in patients withrecurrent pericarditis, with topline results expected in Q2 2024CardiolRx granted U.S. FDA Orphan... ► Artikel lesen | |
| 02.04. | Cardiol Therapeutics Inc reports results for the quarter ended in December - Earnings Summary | 55 | Reuters | ||
| 01.04. | Cardiol Therapeutics Inc. - 20-F, Annual and transition report of foreign private issuers | 16 | SEC Filings | ||
| 29.03. | Cardiol Therapeutics Inc expected to post a loss of 12 cents a share - Earnings Preview | 54 | Reuters | ||
| 22.03. | Cardiol Therapeutics Inc expected to post a loss of 12 cents a share - Earnings Preview | 63 | Reuters | ||
| 27.02. | Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research): Buy / Kursziel: USD 3,60 | 825 | dpa-AFX | Original-Research: Cardiol Therapeutics Inc - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to Cardiol Therapeutics Inc Company Name: Cardiol Therapeutics... ► Artikel lesen | |
| 26.02. | Cardiol Therapeutics Inc. - 6-K, Report of foreign issuer | 66 | SEC Filings | ||
| 21.02. | Cardiol Therapeutics Inc: Cardiol completes patient enrolment for CardiolRx study | 29 | Stockwatch | ||
| 21.02. | Cardiol Therapeutics Inc.: Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx for Recurrent Pericarditis | 390 | Newsfile | This is a Designated News Release.Toronto, Ontario--(Newsfile Corp. - February 21, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences... ► Artikel lesen | |
| 15.02. | Cardiol Therapeutics Inc: Cardiol receives orphan drug designation for CardiolRx | 54 | Stockwatch | ||
| 15.02. | Cardiol Therapeutics Inc.: Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis | 325 | Newsfile | This is a Designated News Release.Toronto, Ontario--(Newsfile Corp. - February 15, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences... ► Artikel lesen | |
| 15.02. | Cardiol Therapeutics Inc. - 6-K, Report of foreign issuer | 23 | SEC Filings | ||
| 30.01. | Cardiol Therapeutics Inc. CEO David Elsley über neue Therapien für akute Myokarditis und wiederkehrende Perikarditis | 1.061 | Kapitalerhöhungen.de | Cardiol Therapeutics Inc. ist ein Biotech-Unternehmen im klinischen Stadium, das sich der Erforschung und klinischen Entwicklung von antiinflammatorischen und antifibrotischen Therapeutika zur Behandlung... ► Artikel lesen | |
| 24.01. | Cardiol Therapeutics Inc: Cardiol regains Nasdaq listing standard compliance | 46 | Stockwatch |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| GAMESTOP | 7.186 |
| TUI | 5.505 |
| NEL | 5.152 |
| EVOTEC | 4.392 |
| NVIDIA | 3.685 |
| PLUG POWER | 2.431 |
| BAYER | 2.236 |
| BYD | 2.171 |
| BIONTECH | 1.777 |
| VOLKSWAGEN | 1.629 |
| RHEINMETALL | 1.573 |
| DEUTSCHE LUFTHANSA | 1.480 |
| SUPER MICRO COMPUTER | 1.389 |
| DEUTSCHE TELEKOM | 1.331 |
| ALLIANZ | 1.116 |
| AIXTRON SE | 1.114 |
| DEUTSCHE BANK | 974 |
| RWE | 962 |
| AMC ENTERTAINMENT | 952 |
| SIEMENS ENERGY | 945 |
| BASF | 935 |
| COMMERZBANK | 893 |
| JINKOSOLAR | 855 |
| AMD | 845 |
| TESLA | 838 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
